Cell-to-cell adhesion as well as the interaction of cells with the extracellular matrix are key phenomena in different physiological and pathological conditions,including embryogenesis,blood coagulation,lymphocyte homing,immune response,angiogenesis,metastasis,thrombosis and inflammation[1,2].Thus,it has been widely proposed that cell adhesion molecules are an important therapeutic target in a wide array of diseases with high impact on public health,including atherosclerosis,thromboembolic disorders,cancer,graft rejection and autoimmune inflammatory conditions[1,2].However,anti-adhesion therapy with either biological agents (mainly blocking monoclonal antibodies,mAbs) or chemical inhibitors (mainly synthetic peptides) has not yet fulfilled these expectations and has not been devoid of undesirable effects[3,4]